Quick Facts

• Relief of Heartburn: May help manage the discomfort associated with acid reflux and sour stomach.
• Acid Indigestion Management: Is indicated for the reduction of symptoms related to acid indigestion.
• Gas and Bloating: May help address feelings of pressure, fullness, and discomfort caused by excess gas.

---

Diovol Plus AF is an established therapeutic option indicated for the management of symptoms associated with excessive stomach acid. It may be used to provide relief of heartburn, which is a common manifestation of gastroesophageal reflux. This medication is also indicated for the reduction of symptoms linked to acid indigestion and sour stomach.

Additionally, Diovol Plus AF includes ingredients that may help address the symptoms of excess gas. This can help manage feelings of pressure, abdominal fullness, and bloating that may accompany digestive distress.

This medication is available over-the-counter and is utilized for temporary symptom relief. Before use, individuals should review product labeling to determine if the product is suitable for their specific health needs. It is recommended to consult a healthcare professional if symptoms persist or worsen.

Regulatory References

1. NIH MedlinePlus guidance

Diovol Plus AF is generally used for the short-term, temporary relief of symptoms like heartburn, acid indigestion, and gas. However, its use is not appropriate for everyone and requires careful consideration of an individual's medical profile.

Who Should NOT Use Diovol Plus AF?

Consultation with a healthcare provider is essential before using this product, especially if you have certain pre-existing conditions. Diovol Plus AF is typically contraindicated in patients with:

• Severe Kidney Impairment: Due to the risk of accumulation of aluminum and magnesium, which can lead to toxicity, particularly with long-term or high-dose use.
• Known Allergy or Hypersensitivity to aluminum hydroxide, magnesium hydroxide, simethicone, or any other component of the formulation.
• Severe Undiagnosed Abdominal Pain or conditions leading to obstruction of the bowel.

Precautions for Use

Special caution is advised for individuals with other health issues or those taking certain medications, as the antacid components can affect absorption. Discuss use with a healthcare professional if you are:

Condition / Status	Rationale for Caution
Pregnant or Breastfeeding	Safety data is limited; use only if clearly needed and advised by a doctor.
On a Magnesium-Restricted Diet	The product contains magnesium hydroxide.
Taking Certain Medications	Antacids can interfere with the absorption of drugs like tetracycline and fluoroquinolone antibiotics, iron supplements, and thyroid hormones. Dosing must be separated by at least 2 to 4 hours.

It is recommended to avoid using this medicine at maximum doses for more than two weeks unless directed by a physician.

Diovol Plus AF Interactions with other medicines and products

The interaction profile of this product, containing Calcium Carbonate and Magnesium Hydroxide, is defined by its potential to alter the absorption of concurrently administered oral medications. Regulatory documentation establishes specific rules and restrictions to mitigate the risk of reduced systemic exposure for many other drugs.

---

Documented Interaction Patterns

The primary documented interaction is reduced systemic exposure of certain medicines, a pharmacokinetic effect that can lower their concentration and effectiveness. This applies to several medicinal product categories:

• Antibiotics: Specifically Tetracyclines and Quinolones (e.g., Ciprofloxacin).
• Other Oral Medicines: Including Thyroid preparations (e.g., Levothyroxine), Iron Supplements, Bisphosphonates, and certain Antivirals (e.g., Raltegravir).

---

Required Administration Rules

To manage the absorption risk, official labeling mandates time separation from other oral drugs:

• General Rule: Avoid taking other oral medicines within 1 to 2 hours of antacid administration.
• Specific Agents: For agents like Eltrombopag, a separation of at least 4 hours is required.

---

Population-Specific Cautions

Official documents note that interactions may be more critical in certain populations:

• Renal Impairment: Due to reduced clearance, the risk of Magnesium toxicity is increased. The co-administration of citrates with aluminum-containing components must also be avoided due to the potential for aluminum accumulation.

Diovol Plus AF operates through two distinct, non-systemic mechanistic domains, resulting in dual physiological consequences within the gastrointestinal tract.

Neutralizing Gastric Acid by Ion Exchange

This domain involves Aluminum Hydroxide and Magnesium Hydroxide, which act as chemical buffers within the stomach lumen. They dissociate to release hydroxide ions ( OH^-), which immediately bind to the free protons ( H^+) of hydrochloric acid ( HCl) via acid-base neutralization. This reaction consumes the HCl and forms water and an insoluble salt, thereby increasing the gastric pH and producing less acidic stomach contents.

Modulating Surface Tension of Intestinal Gas

This domain is governed by Simethicone, an antifoaming agent. It functions as a non-systemic surfactant, acting locally in the stomach and intestines. Simethicone reduces the surface tension of the small, occluded gas bubbles trapped in the digestive tract. This mechanistic cascade allows the numerous small bubbles to coalesce into larger bubbles. The resulting physiological consequence is the facilitation of gas expulsion from the digestive tract via belching or flatus, which modifies the mechanical dynamics within the gastrointestinal system.

Instruction Map: Official Administration Guidelines

Diovol Plus AF is designated for administration solely via the oral route, consistent with its formulation as an Oral Suspension. The product's usage is characterized by parameters that define the appropriate dose volume, maximum daily intake, and duration of use.

Administration Scope	Official Guideline
Route of administration	The medicine is administered exclusively by the oral route.
Dosing schedule (Adults ge 12)	The standard single dose is 10 mL to 20 mL. The total dose administered must not exceed 60 mL in a 24-hour period.
Frequency and Timing	The medicine is generally used as needed for symptoms, with a maximum frequency of four times a day. Doses are often scheduled between meals and at bedtime.
Preparation	The container must be shaken well before use. The dose must be measured accurately using a suitable device. The product may be administered with or without food.
Age-group rules	Intended for adults and children 12 years and over. Use in children under 12 years requires consultation with a physician.

---

Resulting Procedural Structure

The official use protocol requires accurate measurement of the liquid and mandates adherence to the maximum daily intake. This product is designated for short-term use; labeling specifies a restriction on the continuous administration of the maximum dosage to a duration of no more than two weeks. Adherence to these guidelines for route, dose, and frequency is necessary for procedural consistency with the product’s labeled administration.

Research evidence / Overview of studies for Diovol Plus AF

---

1. Evidence Landscape for Heartburn and Acid Indigestion

The research exploring the antacid components (Calcium Carbonate and Magnesium Hydroxide) includes short-term randomized controlled trials and formal scientific reviews. These studies primarily focused on acute symptoms. Researchers monitored the time to change in reported symptoms and the duration of symptom change from acute symptoms such as heartburn and sour stomach. Findings describe patterns observed in the studies, including measurements of measured changes in patient-reported severity scales after taking the medicine.

2. Evidence Landscape for Gas, Bloating, and Abdominal Fullness

The research examined the anti-flatulence component (Simethicone) in relation to symptoms like bloating and abdominal fullness, and includes short-term RCTs and observational studies. Studies observed symptoms associated with acute episodes and focused on patient-reported outcomes describing perceived discomfort. When evaluating the component for general patient gas symptoms, findings were mixed across the broader evidence landscape. Research describes the component's physical properties when observed in laboratory or clinical contexts.

---

3. Study Duration and Follow-up Periods

Clinical trials for the components primarily involve studies conducted during periods of increased symptom activity and focused on short-term symptom changes. For the antacid components, studies frequently monitored responses over defined time intervals up to a maximum of about two weeks. This means that while the evidence contributes to understanding immediate and temporary symptom patterns, there is limited information for long-term outcomes or the durability of response over many months.

4. Summary of Unresolved Research Questions

The existing research provides insight into short-term changes, but certain key limitations remain in the evidence landscape for this combination product. One area of uncertainty relates to the anti-flatulence component, where findings were mixed regarding its effectiveness in reducing patient-reported bloating in all clinical settings. Additionally, long-term outcomes are not fully established for the combination overall, and the clinical relevance of combining all three agents in a fixed dose is an area where comparative evidence is lacking in some scientific reviews.

Key Studies & References

1. Simethicone: MedlinePlus Drug Information
2. Effects of Aluminum/Magnesium Hydroxide and Calcium Carbonate on Esophageal and Gastric pH in Subjects with Heartburn
3. Efficacy and safety of APT036 versus simethicone in the treatment of functional bloating: a multicentre, randomised, double-blind, parallel group, clinical study

Common questions about Diovol Plus AF (FAQ)

Q: Does Diovol Plus AF contain any ingredients that are similar to other over-the-counter heartburn medicines?

Official product information states that Diovol Plus AF contains the antacid ingredients Calcium Carbonate and Magnesium Hydroxide. These mineral compounds are commonly used in many other over-the-counter medicines intended for the temporary relief of heartburn and acid indigestion.

Q: Are there studies that specifically look at the duration of action for Diovol Plus AF?

Research evidence for the antacid components has examined how long the reported symptoms change following administration. Studies of this class of medicine often monitor the time frame over which patients report relief from acute symptoms.

Q: How long does it take for Diovol Plus AF to provide relief according to clinical information?

Clinical studies typically measure the time it takes for patients to report a change in symptoms after taking the medicine. For antacids of this type, symptom changes are commonly described in research literature as occurring within a short time frame.

Q: Does the official documentation mention any long-term use concerns with Diovol Plus AF?

Yes, official warnings emphasize that the product is intended for short-term use only. Regulatory documents state that use of this medicine for a prolonged period or exceeding the maximum recommended duration, such as two weeks, carries an increased risk of serious systemic effects due to the accumulation of minerals.

Q: Is Diovol Plus AF described as being restricted for people with kidney issues, according-to-regulatory labels?

Yes, regulatory labels include specific warnings regarding use in patients with kidney problems. The product is typically contraindicated (not recommended for use) in cases of severe kidney impairment due to the risk of mineral accumulation, such as magnesium and aluminum.

Q: Can Diovol Plus AF be taken around the same time as high blood pressure medication? (Informational)

Official labeling mandates that a time separation (usually 1 to 2 hours) is required to be maintained between taking Diovol Plus AF and other oral medications. This rule applies to all oral medicines, including those for high blood pressure, to prevent the antacid components from interfering with drug absorption.

Q: Does Diovol Plus AF have the potential to interact with herbal supplements?

While official interaction profiles focus on prescription and over-the-counter medicines, the general interaction rule regarding time separation may also apply to certain oral herbal supplements. This separation is intended to manage the risk of reduced absorption of the other product.

Q: Are there any foods that officially need to be avoided when using Diovol Plus AF?

Official instructions state the medicine may be administered with or without food. However, warnings caution against taking aluminum-containing components alongside products or foods containing citrate, as this combination may increase the absorption risk of aluminum.

Q: Does taking Diovol Plus AF affect the results of any common medical tests?

Regulatory documents sometimes include information about potential interference with laboratory test results. The possibility exists for the levels of calcium and magnesium in the blood to be transiently affected by antacids.

Q: What official warnings exist regarding Diovol Plus AF use during pregnancy?

Official regulatory warnings note that safety data is limited regarding the use of this product during pregnancy and breastfeeding. For this reason, official guidance recommends using the product only if clearly needed and under the direction of a healthcare professional.

Q: Is the active ingredient in Diovol Plus AF naturally sourced or synthetic?

The ingredients in Diovol Plus AF are sourced from both mineral and synthetic origins. The antacid components, Calcium Carbonate and Magnesium Hydroxide, are mineral-derived, while the anti-flatulence component, Simethicone, is a synthetic polymer.

Q: What is the difference between Diovol Plus AF and other popular antacids?

Regulatory classification describes Diovol Plus AF as a combination product, which sets it apart from simple antacids. It combines the action of mineral antacids, which neutralize stomach acid, with the action of Simethicone, an anti-flatulence agent that helps manage gas and bloating.

Q: Has there been research on Diovol Plus AF use in the elderly population?

While specific studies on the elderly are not the primary focus of the evidence, regulatory documents include safety warnings for use in older adults. These warnings often focus on the potential for increased risk associated with impaired renal function in this population.

Q: Are there any known interactions between Diovol Plus AF and common pain relievers?

Regulatory guidance mandates that a time separation of one to two hours be maintained between Diovol Plus AF and all other oral medicines, including common pain relievers. This is due to the potential for antacids to interfere with the absorption of other medications.

Q: Is Diovol Plus AF considered a cure for the condition it treats, or just a management tool?

Official labeling indicates that Diovol Plus AF is designated for the short-term, temporary relief of symptoms like heartburn, acid indigestion, and gas. It is classified as a symptomatic management tool and is not indicated as a cure for underlying conditions.

Q: Does the product information mention any potential for dependency on Diovol Plus AF?

As a non-systemic, over-the-counter medicine, dependency is not typically listed as a risk in regulatory documents. However, official warnings emphasize the risks associated with prolonged use and exceeding the recommended duration, as this can lead to mineral accumulation and serious systemic effects.

Q: Are there any specific ingredients in Diovol Plus AF that can cause allergic reactions?

Official documentation states that the product should not be used by individuals with a known allergy or hypersensitivity to its active ingredients. These include aluminum hydroxide, magnesium hydroxide, simethicone, or any other component of the formulation.

Q: Are there known interactions between Diovol Plus AF and diabetes medications?

Like other oral medications, diabetes medications may be subject to reduced absorption when taken too close to an antacid. For this reason, official guidance mandates a time separation of 1 to 2 hours between Diovol Plus AF and all other oral medicines.

Q: Does official guidance mention taking Diovol Plus AF with specific types of liquid?

Official guidance confirms that Diovol Plus AF must be administered via the oral route and may be taken with or without food. However, the instructions do not specify a required type of liquid for administration.

Q: Is it a common misunderstanding that Diovol Plus AF treats stomach ulcers?

The product is officially indicated for the temporary relief of symptoms associated with hyperacidity, such as heartburn and acid indigestion. It is not indicated for the underlying treatment or cure of medical conditions like stomach ulcers.

Q: What official resources provide detailed information on the components of Diovol Plus AF?

Detailed official information about the product's components and uses is found in regulatory documents. These resources include the official U.S. Food and Drug Administration (FDA) Drug Labels (published via DailyMed) and the Health Canada Monograph for the medicine.

Q: Are there any official warnings about driving or operating machinery while using Diovol Plus AF?

Official warnings primarily focus on serious systemic side effects related to mineral accumulation, and patients should be mindful of potential impairment before driving or operating machinery.

Q: What is the typical shelf life of an unopened package of Diovol Plus AF?

The official shelf life for an unopened package is determined by the expiration date printed on the packaging. This date is set by the manufacturer based on stability testing and assumes the product has been stored according to the stated conditions.

Q: Are there any specific patient characteristics that make Diovol Plus AF less suitable?

Yes, official documentation lists certain patient characteristics that make the product unsuitable for use. These include having severe kidney impairment, a known allergy to any ingredient, or conditions leading to obstruction of the bowel.

Storage Requirements

Diovol Plus AF Oral Suspension must be stored at controlled room temperature, which is typically defined as between 15°C and 30°C (59°F and 86°F). It is mandatory to store the medicine in its original container and keep the container tightly closed when not in use. The product must be protected from excessive heat and direct sunlight, and it must not be frozen. As with all medicines, it should be kept out of the sight and reach of children.

---

Disposal Instructions

Unused or expired Diovol Plus AF must be disposed of safely. The preferred method is to utilize an authorized drug take-back program or mail-back envelope. If a take-back option is unavailable, the medicine should be mixed with an unappealing substance, sealed in a bag, and placed in household trash. It is officially mandated not to flush the product down the toilet or throw it into wastewater. All personal information should be removed from the packaging before disposal.